Huons Provides Patient Payment System for Convenience of Diabetes Patients

Continuous Glucose Monitor Dexcom G6 Now Available in Korea

An image showing the recently released continuous glucose monitor Dexcom G6 worn in Korea

[Asia Economy Reporter Choi Dae-yeol] The health insurance coverage criteria for continuous glucose monitors used by patients with type 1 diabetes, a congenital disease, will change from a weekly basis to a daily basis as early as next month.

The existing Dexcom products, which are widely sold both domestically and globally, used electrodes (sensors) on a weekly basis, but the new product released in Korea last month can be used for ten days, necessitating a revision of the coverage criteria. Huons, responsible for domestic sales, decided to keep the price of the new Dexcom G6 the same as before and to provide a patient payment system and proxy claim service through the official sales site for the convenience of diabetes patients.

Diabetes patients need to frequently check their blood sugar and inject insulin for stable management. Continuous glucose monitors reduce the burden of blood sampling and the possibility of hypoglycemia, gaining attention as an effective treatment method both domestically and internationally. The Dexcom G6 automatically measures blood glucose every 5 minutes, up to 288 times a day, and the values can be viewed on a smartphone without the patient needing to pay special attention. Especially for type 1 diabetes patients, the feature that alerts in advance of hypoglycemia is very useful. It sends an alarm 20 minutes before the user's blood sugar reaches a very low level to help take preventive measures.

Continuous Glucose Monitor Dexcom G6

It is also useful for type 2 diabetes patients or those with impaired fasting glucose due to lifestyle habits. After meals, a rapid rise in blood sugar called a 'blood sugar spike' can occur, and if repeated, it can damage vascular endothelial cells and cause inflammation. The Dexcom G6 automatically measures blood sugar every 5 minutes, providing more detailed blood sugar values and fluctuation trends than typical postprandial blood sugar measurements. This makes it easier to estimate how much and what kind of food to eat.

A Huons official said, "The accuracy error rate has improved, and taking acetaminophen does not affect blood sugar monitoring," adding, "The one-touch method makes sensor attachment easier, and the transmitter is thinner, allowing comfortable wear under clothing."